Clinical trial
The Effects of Thalidomide on Symptom Clusters
NCT00379353 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00379353 |
|---|---|
| Title | The Effects of Thalidomide on Symptom Clusters |
| Official title | The Effects of Thalidomide on Symptom Clusters |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Celgene Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Cancers |
| Intervention type | Drug |
| Interventions | Thalidomide, Placebo |
| Enrollment | 32 |
| Start date | Sep 1, 2006 |
| Primary completion | Jan 1, 2013 |
| Completion | Jan 1, 2013 |
| First posted | Sep 21, 2006 |
| Last update posted | Feb 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: